Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janbernd Kirschner

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
The Lancet. Neurology|March 20, 2024
New therapeutic avenues for Duchenne muscular dystrophyJanbernd Kirschner
Journal of Perinatal Medicine|September 9, 2021
Postnatal gene therapy for neuromuscular diseases - opportunities and limitationsJanbernd Kirschner
Handbook of Clinical Neurology|April 30, 2013
Congenital muscular dystrophiesJanbernd Kirschner
Neuropediatrics|June 2, 2017
Diagnosis and New Treatment Avenues in Spinal Muscular AtrophyAstrid Pechmann, Janbernd Kirschner
Handbook of Clinical Neurology|April 19, 2011
SarcoglycanopathiesJanbernd Kirschner, Hanns Lochmüller
Developmental Medicine and Child Neurology|June 7, 2017
Outcomes in Duchenne muscular dystrophy: nature, nurture, culture-or all three?Thorsten Langer, Janbernd Kirschner
Cell and Tissue Research|May 15, 2010
Elevated satellite cell number in Duchenne muscular dystrophyMichael Kottlors, Janbernd Kirschner
Deutsches Arzteblatt International|February 27, 2021
Gene Therapy for Monogenic Inherited DisordersJanbernd Kirschner, Toni Cathomen
Archives of Neurology|February 18, 2004
The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundariesJanbernd Kirschner, Carsten G Bönnemann
Neuromuscular Disorders : NMD|May 4, 2020
Randomisation versus prioritisation in a managed access programme: Lessons from spinal muscular atrophyLaurent Servais, Janbernd Kirschner, Francesco Muntoni
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
The Lancet. Neurology|March 20, 2024
New therapeutic avenues for Duchenne muscular dystrophyJanbernd Kirschner
Journal of Perinatal Medicine|September 9, 2021
Postnatal gene therapy for neuromuscular diseases - opportunities and limitationsJanbernd Kirschner
Handbook of Clinical Neurology|April 30, 2013
Congenital muscular dystrophiesJanbernd Kirschner
Neuropediatrics|June 2, 2017
Diagnosis and New Treatment Avenues in Spinal Muscular AtrophyAstrid Pechmann, Janbernd Kirschner
Handbook of Clinical Neurology|April 19, 2011
SarcoglycanopathiesJanbernd Kirschner, Hanns Lochmüller
Developmental Medicine and Child Neurology|June 7, 2017
Outcomes in Duchenne muscular dystrophy: nature, nurture, culture-or all three?Thorsten Langer, Janbernd Kirschner
Cell and Tissue Research|May 15, 2010
Elevated satellite cell number in Duchenne muscular dystrophyMichael Kottlors, Janbernd Kirschner
Deutsches Arzteblatt International|February 27, 2021
Gene Therapy for Monogenic Inherited DisordersJanbernd Kirschner, Toni Cathomen
Archives of Neurology|February 18, 2004
The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundariesJanbernd Kirschner, Carsten G Bönnemann
Neuromuscular Disorders : NMD|May 4, 2020
Randomisation versus prioritisation in a managed access programme: Lessons from spinal muscular atrophyLaurent Servais, Janbernd Kirschner, Francesco Muntoni
Pageof 18